Bill number does not exist. Enter a vaild keyword.
Original
Chamber
1st
Reading
Referral
to Cmte
2nd
Reading
3rd
Reading
Opposite
Chamber
1st
Reading
Referral
to Cmte
2nd
Reading
3rd
Reading
Review in
Original Chamber
Passed Both
Chambers
Conf. Cmte
(if necessary)
To Governor
Title
Public Health - Opioid Overdose Reversal Drugs - Standing Orders
Sponsored by
Senator Klausmeier
Status
In the Senate - Hearing 2/20 at 1:00 p.m.
Analysis
Fiscal and Policy Note
Synopsis
Requiring a licensed health care provider, when issuing a standing order for an opioid reversal drug, to allow an individual to choose any formulation of any opioid reversal drug approved by the federal Food and Drug Administration.
Committees
Details
Cross-filed with: HB0411
Bill File Type: Regular
Effective Date(s): October 1, 2024
Legislation History
Chamber
Senate
Calendar Date
1/18/2024
Legislative Date
1/18/2024
Action
First Reading Finance
Proceedings
Chamber
Calendar Date
Legislative Date
Action
Text - First - Public Health - Opioid Overdose Reversal Drugs - Standing Orders
Proceedings
Chamber
Senate
Calendar Date
1/31/2024
Legislative Date
1/31/2024
Action
Hearing 2/20 at 1:00 p.m.
Proceedings
Chamber Calendar Date Legislative Date Action Proceedings
Senate 1/18/2024 1/18/2024 First Reading Finance
Text - First - Public Health - Opioid Overdose Reversal Drugs - Standing Orders
Senate 1/31/2024 1/31/2024 Hearing 2/20 at 1:00 p.m.
Last Updated: 2/21/2024 11:15 AM
Click to return on the top page